NCT06784791
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06784791
Title Preoperative Amivantamab or Amivantamab and Carboplatin/pemetrexed Treatment in Patients with Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR) (NEOpredict-EGF)
Acronym NEOpredict-EGF
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Essen
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | DEU | BEL

Facility Status City State Zip Country Details
Jessa Ziekenhuis, Department of Pneumology RECRUITING Hasselt 3500 Belgium Details
Thoraxklinik Heidelberg gGmbH, Studienzentrum Thoraxonkologie RECRUITING Heidelberg Baden-Wurttemberg 69126 Germany Details
West German Cancer Center, Department of Medical Oncology, University Hospital Essen RECRUITING Essen Germany 45147 Germany Details
Erasmus Universitair Medisch Centrum Rotterdam Department of Pulmonary Medicine RECRUITING Rotterdam 3015 GD Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field